Explore comprehensive CDMO services offered by Pillar5 Pharma, supporting end-to-end Anlaytical Testing, Drug Development and Manufacturing. Pillar5 Pharma enables faster, compliant, and scalable pharma innovation tailored to your needs.
Country: Canada, U.S.A.
Description: Pillar5 Pharma is a Canadian Contract Development and Manufacturing Organization (CDMO) founded in 2009 that specializes in sterile ophthalmic solutions and solid dose products. Based in Arnprior, Ontario, the company is a market leader in Multi-Dose Preservative Free (MDPF) technology and was acquired by ANJAC SAS in March 2022.
